ZA934907B - 5,10-methylentetrahydrofolic acid-cyclodextrin inclusion compounds - Google Patents

5,10-methylentetrahydrofolic acid-cyclodextrin inclusion compounds

Info

Publication number
ZA934907B
ZA934907B ZA934907A ZA934907A ZA934907B ZA 934907 B ZA934907 B ZA 934907B ZA 934907 A ZA934907 A ZA 934907A ZA 934907 A ZA934907 A ZA 934907A ZA 934907 B ZA934907 B ZA 934907B
Authority
ZA
South Africa
Prior art keywords
acid
cyclodextrin inclusion
methylentetrahydrofolic
inclusion compounds
compounds
Prior art date
Application number
ZA934907A
Other languages
English (en)
Inventor
Hans Rudolf Mueller
Martin Ulmann
Josef Conti
Original Assignee
Eprova Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eprova Ag filed Critical Eprova Ag
Publication of ZA934907B publication Critical patent/ZA934907B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Ink Jet Recording Methods And Recording Media Thereof (AREA)
  • Ink Jet (AREA)
ZA934907A 1992-07-13 1993-07-08 5,10-methylentetrahydrofolic acid-cyclodextrin inclusion compounds ZA934907B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH2192/92A CH684644A5 (de) 1992-07-13 1992-07-13 5,10-Methylentetrahydrofolsäure-Cyclodextrin-Einschlussverbindungen.

Publications (1)

Publication Number Publication Date
ZA934907B true ZA934907B (en) 1994-02-09

Family

ID=4228046

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA934907A ZA934907B (en) 1992-07-13 1993-07-08 5,10-methylentetrahydrofolic acid-cyclodextrin inclusion compounds

Country Status (18)

Country Link
US (1) US5455236A (fr)
EP (1) EP0579996B1 (fr)
JP (1) JP2667354B2 (fr)
KR (1) KR100217788B1 (fr)
CN (1) CN1032901C (fr)
AT (1) ATE121949T1 (fr)
AU (1) AU661591B2 (fr)
CA (1) CA2100126C (fr)
CH (1) CH684644A5 (fr)
DE (1) DE59300176D1 (fr)
DK (1) DK0579996T3 (fr)
ES (1) ES2072163T3 (fr)
FI (1) FI933151A7 (fr)
HU (2) HU212665B (fr)
NO (1) NO303715B1 (fr)
RU (1) RU2135519C1 (fr)
TW (1) TW379142B (fr)
ZA (1) ZA934907B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5906981A (en) * 1996-06-04 1999-05-25 Troy Corporation Halopropargyl inclusion complexes
CH693255A5 (de) * 1997-06-13 2003-05-15 Eprova Ag Verwendung von Tetrahydrofolaten in der natürlichenstereoisomeren Form zur Herstellung einer pharmazeutischenZubereitung geeignet zur Beeinflussung des Homocystein-Spiegels.
CN1095472C (zh) * 2000-04-17 2002-12-04 上海复康医药科技发展有限公司 叶酸－多聚糖复合物，其制备方法和以该复合物为活性成分的药物组合物
KR20060051135A (ko) * 2004-09-15 2006-05-19 니프로 가부시키가이샤 안정화된 주사용 수용액 제재
AU2008222592B2 (en) 2007-03-02 2013-09-26 Detsamma Investments Pty Ltd Compositions and methods for delivery of anti-cancer agents
CN101235102B (zh) * 2008-02-18 2010-11-03 南昌航空大学 一种叶酸偶联羟丙基壳聚糖纳米微粒的制备方法
CN102000345A (zh) * 2010-11-16 2011-04-06 广西大学 包合态的叶酸/β-环糊精组合物及其制备方法
CN102258788B (zh) * 2011-06-13 2012-11-07 南开大学 一种靶向传递阿霉素抗癌药的组装体及其制备方法
EP2837631A1 (fr) * 2013-08-14 2015-02-18 Merck & Cie Nouveau sel stable d'acide 5,10-méthylène-(6R)-tétrahydrofolique
RU2537246C1 (ru) * 2013-10-17 2014-12-27 Федеральное государственное бюджетное учреждение "Научный центр клинической и эскпериментальной медицины" Сибирского отделения Российской академии медицинских наук ФГБУ "НЦКЭМ" СО РАМН Способ получения биотинилированного производного окисленного декстрана
EP2878600B1 (fr) 2013-12-02 2018-06-27 Cerbios-Pharma S.A. Complexes stables d'un sel de métal alcalino-terreux d'acide N5-méthyl-tétrahydrofolique et un polyol
ES2902051T3 (es) 2017-08-16 2022-03-24 Merck Patent Gmbh Liofilizados estables que contienen ácido 5,10-metilen-(6R)-tetrahidrofólico y un ácido dicarboxílico
CN112089848A (zh) * 2020-10-27 2020-12-18 浙江诺得药业有限公司 叶酸的环糊精包合物及其制备方法
EP4536185A1 (fr) 2022-06-08 2025-04-16 Merck Patent GmbH Compositions pharmaceutiques stables comprenant de l'acide 5,10-méthylène-(6r)-tétrahydrofolique et du nacl
WO2023237485A1 (fr) 2022-06-08 2023-12-14 Merck Patent Gmbh Lyophilisats stables comprenant de l'acide 5,10-méthylène-(6r)-tétrahydrofolique
EP4536186A1 (fr) 2022-06-08 2025-04-16 Merck Patent GmbH Solutions concentrées comprenant de l'acide 5,10-méthylène-(6r)-tétrahydrofolique
WO2023237482A1 (fr) 2022-06-08 2023-12-14 Merck Patent Gmbh Solutions concentrées comprenant du 5,10-méthylène-(6r)-tétrahydrofolate de sodium
CN117771389A (zh) * 2023-12-28 2024-03-29 浙江圣达生物药业股份有限公司 L-5-甲基四氢叶酸钙-γ-环糊精包合物及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0031237B1 (fr) * 1979-12-19 1984-10-17 National Research Development Corporation Dérivés de la quinazoline, procédés pour leur préparation, compositions les contenant et leur utilisation comme agents anticancéreux
US4350659A (en) * 1981-07-30 1982-09-21 Corning Glass Works Stabilization of sensitive biologically active intermediate metabolites such as folic acid derivatives
JPS602775B2 (ja) 1981-08-28 1985-01-23 富士通株式会社 モニタ機能付大規模集積回路及びその製造方法
JPS59175432A (ja) * 1983-03-25 1984-10-04 Yatoron:Kk ジヒドロ葉酸溶液の安定化方法
JPS62281855A (ja) * 1986-05-29 1987-12-07 Daikin Ind Ltd ビタミン，ビタミン誘導体，またはホルモンを含有する包接化合物
GB8621268D0 (en) * 1986-09-03 1986-10-08 Univ Strathclyde Separation of substances
US4857530A (en) * 1987-11-03 1989-08-15 Warner-Lambert Company Substituted quinazolinones as anticancer agents
NL8901432A (nl) * 1989-06-06 1991-01-02 Pharmachemie Bv Bij koelkasttemperatuur stabiele waterige folinaatoplossing, alsmede werkwijze ter bereiding daarvan.
CA2021042A1 (fr) 1989-07-21 1991-01-22 Fabrizio Marazza Sels de l'acide n,n-methylene-5,6,7,8-tetrahydrofolique
ES2076263T3 (es) 1989-08-21 1995-11-01 American Cyanamid Co Formulacion farmaceutica inyectable estable, para acido folico y sales de leucovorina y procedimiento.
IT1237509B (it) 1989-10-31 1993-06-08 Magis Farmaceutici Complessi con le ciclodestrine indicati per il trattamento di tutte leforme anemiche da carenza di folati, loro preparazione e relative composizioni farmaceutiche
CH680731A5 (fr) * 1990-04-12 1992-10-30 Sapec Fine Chemicals
WO1991017660A1 (fr) 1990-05-11 1991-11-28 Spears Colin P 5,10-methylene-tetrahydrofolate comme modulateur d'un agent chimiotherapeutique
US5153309A (en) * 1990-07-27 1992-10-06 The United States Of America As Represented By The Department Of Health And Human Services Process of making tetrahydropteroylpoly-l-glutamic acid derivatives
CH681303A5 (fr) 1991-01-16 1993-02-26 Eprova Ag
KR100207360B1 (ko) * 1991-06-14 1999-07-15 돈 더블유. 슈미츠 이미다조[1,5,-a]퀸옥살린

Also Published As

Publication number Publication date
AU4187093A (en) 1994-01-20
FI933151A0 (fi) 1993-07-09
HUT65714A (en) 1994-07-28
JP2667354B2 (ja) 1997-10-27
ES2072163T3 (es) 1995-07-01
HU211484A9 (en) 1995-11-28
ATE121949T1 (de) 1995-05-15
JPH0718084A (ja) 1995-01-20
HU212665B (en) 1996-09-30
CN1032901C (zh) 1996-10-02
DE59300176D1 (de) 1995-06-08
KR100217788B1 (ko) 1999-09-01
KR940002301A (ko) 1994-02-17
CN1081688A (zh) 1994-02-09
HU9301990D0 (en) 1993-09-28
FI933151L (fi) 1994-01-14
CA2100126C (fr) 1998-05-05
NO932517D0 (no) 1993-07-09
EP0579996A1 (fr) 1994-01-26
FI933151A7 (fi) 1994-01-14
NO932517L (no) 1994-01-14
EP0579996B1 (fr) 1995-05-03
CA2100126A1 (fr) 1994-01-14
US5455236A (en) 1995-10-03
AU661591B2 (en) 1995-07-27
NO303715B1 (no) 1998-08-24
TW379142B (en) 2000-01-11
RU2135519C1 (ru) 1999-08-27
DK0579996T3 (da) 1995-07-10
CH684644A5 (de) 1994-11-15

Similar Documents

Publication Publication Date Title
AU661591B2 (en) 5,10-methylenetetrahydrofolic acid-cyclodextrin inclusion compounds
HU9401445D0 (en) Nor-bile-acid derivatives, process for producing them and pharmaceutical compositions containing them
OA09772A (en) "mometasone furoate monohydrate, process for making same and pharmaceutical compositions".
HUT70526A (en) Indole-2-carboxylic acid derivatives, process for producing thereof and pharmaceutical compositions comprising same compounds
HU9501812D0 (en) Atovaquone pharmaceutical compositions
IL103516A0 (en) Cytotoxic bicyclo(7,3,1)tridec-4-ene-2,6-diyne compounds,process for the preparation thereof and pharmaceutical compositions containing them
HU903961D0 (en) Process for producing 11-beta-aryl-4-oestrenes and pharmaceutical preparatives containing these compounds
HUT48624A (en) Process for producing 6-benzoxazinyl- and 6-benzothiazinyl-2,3,4,5-tetrahydropyridazin-3-ones and pharmaceutical compositions comprising such compounds
FI894899A0 (fi) Menetelmä dispergoituvan kiinteän lääkeainekoostumuksen valmistamiseksi
HUT62003A (en) Process for producing 1,3-benzoxazine derivatives and pharmaceutical compositions comprising such compounds
GR3015634T3 (en) Process for the preparation of micronised biodegradable particles.
HUT50790A (en) Process for producing new 3,5-dihydroxycarboxylic acids and derivatives thereof, as well as pharmaceutical compositions and intermediates comprising such compounds
RU93047800A (ru) 5,10-метилентетрагидрофол кислоты - циклодекстрин - соединения, образующие среду для заключения препаратов
HUT46664A (en) Process for producing new dihydropyridineamide derivatives and pharmaceutical compositions comprising these compounds
HUT59819A (en) Process for producing stabilized pharmaceutical compositions
HUT49332A (en) Process for producing n-/substituted -alkylidene/-1,2,3,4-tetrahydro-9-acridin-amides and pharmaceutical compositions containing them
HUT47132A (en) Process for producing new 2beta, 16beta-diamono-androstane derivatives and pharmaceutical compositions comprising such compounds
HU904582D0 (en) Process for producing amino-oligohydroxi derivatives and pharmaceutical preparatives containing those compounds
HUT68249A (en) 2,6-methano-2h-quinolizin derivative as 5-ht3-receptor and pharmaceutical composition containing it and process for producing thereof
ZA919912B (en) Novel 15-nitro-2beta,3beta-dihydro-and 15-nitro-2beta,3beta,6,7-tetrahydrotabersonine derivatives,pharmaceutical compositions containing them and process for preparing same
HUT54682A (en) Process for producing 13-bromine- and 13,14-dibromine-ergoline derivatives and pharmaceutical preparatives containing these compounds
HU9400909D0 (en) 1,2,5,6-terrahydro-pyridine derivative pharmaceutical compositions containing them and process for producing them
HUT61776A (en) Process for producing 3' and/or 4' oh-modificated elsamycin derivatives and pharmaceutical compositions containing them as active components
HUT69405A (en) Process for producing water-soluble pharmaceutical compositions
HUT59909A (en) Process for producing 5-phenyl-1h-pyrazol-4-propionic acid derivatives and pharmaceutical compositions containing them